Correction for Han et al., “In Vitro Susceptibility of Hepatitis C Virus Genotype 1 through 6 Clinical Isolates to the Pangenotypic NS3/4A Inhibitor Voxilaprevir”

Podobne zapisy

• In Vitro Susceptibility of Hepatitis C Virus Genotype 1 through 6 Clinical Isolates to the Pangenotypic NS3/4A Inhibitor Voxilaprevir
  od: Han, Bin, i wsp.
  Wydane: (2019)
• Sequencing Analysis of NS3/4A, NS5A, and NS5B Genes from Patients Infected with Hepatitis C Virus Genotypes 5 and 6
  od: Ku, Karin S., i wsp.
  Wydane: (2016)
• Clinical and In Vitro Resistance to GS-9669, a Thumb Site II Nonnucleoside Inhibitor of the Hepatitis C Virus NS5B Polymerase
  od: Dvory-Sobol, Hadas, i wsp.
  Wydane: (2014)
• Abundant Drug-Resistant NS3 Mutants Detected by Deep Sequencing in Hepatitis C Virus-Infected Patients Undergoing NS3 Protease Inhibitor Monotherapy
  od: Svarovskaia, Evguenia S., i wsp.
  Wydane: (2012)
• L159F and V321A Sofosbuvir-Associated Hepatitis C Virus NS5B Substitutions
  od: Svarovskaia, Evguenia S., i wsp.
  Wydane: (2016)